Avidity Biosciences, Inc.
RNA
$71.45
-$0.13-0.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -549.79M | -455.74M | -369.22M | -322.30M | -280.49M |
| Total Depreciation and Amortization | 3.39M | 3.05M | 2.92M | 2.78M | 2.65M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.95M | 44.29M | 38.44M | 33.21M | 32.83M |
| Change in Net Operating Assets | -88.09M | -81.57M | -27.46M | -14.56M | 60.50M |
| Cash from Operations | -580.54M | -489.98M | -355.32M | -300.87M | -184.50M |
| Capital Expenditure | -11.72M | -12.72M | -9.90M | -7.07M | -4.01M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -297.70M | -191.20M | -654.36M | -847.14M | -734.98M |
| Cash from Investing | -309.43M | -203.91M | -664.27M | -854.20M | -738.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 869.80M | 361.90M | 805.00M | 1.05B | 1.07B |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -154.00K | 141.40M | 141.40M |
| Cash from Financing | 869.80M | 361.90M | 804.85M | 1.19B | 1.21B |
| Foreign Exchange rate Adjustments | 138.00K | 154.00K | 39.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.03M | -331.84M | -214.70M | 37.29M | 287.04M |